Doxorubicin/eribulinLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75796-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[31] Cytarabine/doxorubicin/hydroxycarbamideLack of efficacy: case report
Reactions Weekly, 2023, 1962 (1) : 152 - 152
[32] Doxorubicin/ifosfamide/pazopanibLack of efficacy: case report
Reactions Weekly, 2024, 2026 (1) : 115 - 115
[33] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1948 (1) : 149 - 149
[34] Doxorubicin-liposomalLack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 236 - 236
[35] Carboplatin/doxorubicin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2025, 2041 (1) : 98 - 98
[36] Dacarbazine/doxorubicin/vinblastineLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 173 - 173
[37] Cisplatin/doxorubicin/methotrexateLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 158 - 158
[38] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1977 (1) : 117 - 117
[39] Doxorubicin/ifosfamide/pazopanibLack of efficacy: case report
Reactions Weekly, 2025, 2052 (1) : 158 - 158
[40] Doxorubicin-liposomalLack of efficacy: case report
Reactions Weekly, 2024, 2027 (1) : 180 - 180

← 1 2 3 4 5 →